España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Hims & Hers Health
HIMS
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$49.28
-17.13
-25.79%
At close: -
$49.00
-0.28
-0.57%
After Hours: 7:59 PM EDT
Get Report
Comment
Q4 2024 earnings tomorrow on Mon Feb 24th after the market close
Conference call scheduled tomorrow at 17:00 PM
Click to view the webcast
At-Home Lab Testing Facility was acquired by Hims & Hers Health (HIMS) on Wednesday, February 19, 2025
Hims & Hers Health (HIMS) Forecast
News
Earnings
Hims & Hers Health (HIMS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Hims & Hers Health (NYSE:HIMS) Stock
Hims & Hers Health Stock (NYSE: HIMS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, February 21, 2025
What's Going On With Hims & Hers Health Stock Today?
Akanksha Bakshi
FDA Says Does Not Intend To Take Action Again...
Benzinga Newsdesk
FDA Says Novo Nordisk's Ozempic Injection .68...
Benzinga Newsdesk
Top 10 Trending Stocks On WallStreetBets As O...
Benzinga Newsdesk
Hims & Hers Health shares are trading lower a...
Benzinga Newsdesk
Hims & Hers Acquires U.S.-based Peptide Facil...
Benzinga Newsdesk
Thursday, February 20, 2025
Market Whales and Their Recent Bets on HIMS Options
Benzinga Insights
B of A Securities Maintains Underperform on H...
Benzinga Newsdesk
Wednesday, February 19, 2025
Garmin Posts Better-Than-Expected Results, Joins SolarEdge Technologies, Compass, Appian And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Hims & Hers Health Stock Hits All-Time Highs: What's Going On?
Adam Eckert
Hims & Hers Health shares are trading higher ...
Benzinga Newsdesk
Canaccord Genuity Maintains Buy on Hims & Her...
Benzinga Newsdesk
Hims & Hers Acquires An At-Home Lab Testing F...
Benzinga Newsdesk
Tuesday, February 18, 2025
This Moderna Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Avi Kapoor
Coinbase To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
Assessing Hims & Hers Health: Insights From 7 Financial Analysts
Benzinga Insights
Morgan Stanley Downgrades Hims & Hers Health ...
Benzinga Newsdesk
Sunday, February 16, 2025
Super Micro Computer, Intel, Alibaba And CVS Are Among Top 13 Large-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
Lekha Gupta
Thursday, February 13, 2025
Hims & Hers Health shares are trading higher....
Benzinga Newsdesk
Robinhood, Gilead Sciences, Crocs, Lincoln Electric, HubSpot, GE HealthCare And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Wednesday, February 12, 2025
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Monday, February 10, 2025
Hims & Hers Health Unusual Options Activity For February 10
Benzinga Insights
Super Bowl Commercials 2025: Complete List of Super Bowl LIX Ads And Companies Behind Them
Chris Katje
US Stocks To Open On A Positive Note After A String Of Bad Mondays: Recent Dip Has 'Reached Its Low Point,' Says Technical Analyst
Rishabh Mishra
Friday, February 07, 2025
"Hims & Hers Faces Scrutiny From Lawmakers Ov...
Benzinga Newsdesk
EXCLUSIVE: Is Super Bowl $7M Ad Cost Worth It? 61% Say No, 18% Say They Looked Up Companies After Last Year's NFL Championship
Chris Katje
Hims & Hers Health Unusual Options Activity
Benzinga Insights
Super Bowl LIX Commercials: AI, Celebs, Muppets, Warren Buffett-Linked Brand Take The Spotlight
Chris Katje
Monday, February 03, 2025
Hims & Hers Health Unusual Options Activity For February 03
Benzinga Insights
Sunday, February 02, 2025
Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?
Lekha Gupta
Tuesday, January 28, 2025
A Closer Look at Hims & Hers Health's Options Market Dynamics
Benzinga Insights
Tuesday, January 21, 2025
Hims & Hers Health Unusual Options Activity
Benzinga Insights
Monday, January 20, 2025
8 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Thursday, January 16, 2025
U.S. FDA Chief Califf Says Current Regulation...
Benzinga Newsdesk
Tuesday, January 14, 2025
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Monday, January 13, 2025
Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment
Benzinga Insights
Friday, January 10, 2025
Watching Hims & Hers Health; Traders Circulat...
Benzinga Newsdesk
Hims & Hers Health shares are trading lower a...
Benzinga Newsdesk
Citigroup Downgrades Hims & Hers Health to Se...
Benzinga Newsdesk
Thursday, January 09, 2025
What's Going On With Hims & Hers Health Stock?
Henry Khederian
Wednesday, January 08, 2025
'Meta Ad Changes Threaten Telehealth's Weight...
Benzinga Newsdesk
Tuesday, January 07, 2025
BTIG Initiates Coverage On Hims & Hers Health...
Benzinga Newsdesk
Monday, January 06, 2025
What 12 Analyst Ratings Have To Say About Hims & Hers Health
Benzinga Insights
Piper Sandler Maintains Neutral on Hims & Her...
Benzinga Newsdesk
Needham Maintains Buy on Hims & Hers Health, ...
Benzinga Newsdesk
Tuesday, December 31, 2024
Options Movement At Hims & Hers Health: Melissa Baird Exercises Worth $658K
Benzinga Insights
Thursday, December 26, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Spotlight on Hims & Hers Health: Analyzing the Surge in Options Activity
Benzinga Insights
Thursday, December 19, 2024
Hims & Hers Health Are Falling Today: What's Going On?
Vaishali Prayag
Hims & Hers Health shares are trading lower a...
Benzinga Newsdesk
Show More